Literature DB >> 7642437

A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis.

P Rubin1, C J Johnston, J P Williams, S McDonald, J N Finkelstein.   

Abstract

PURPOSE: Radiation-induced pulmonary reactions have classically been viewed as distinct phases--acute pneumonitis and, later, fibrosis--occurring at different times after irradiation and attributed to different target cell populations. We prefer to view these events as a continuum, with no clear distinction between the temporal sequence of the different pulmonary reactions; the progression is the result of an early activation of an inflammatory reaction, leading to the expression and maintenance of a cytokine cascade. In the current study, we have examined the temporal and spatial expression of cytokine and extracellular matrix messenger ribonucleic acid (mRNA) abundance in fibrosis-sensitive mice after thoracic irradiation. METHODS AND MATERIALS: Radiation fibrosis-prone (C57BL/6) mice received thoracic irradiation of 5 and 12.5 Gy. At Day 1, and 1, 2, 8, 16, and 24 weeks after treatment, animals were killed and lung tissue processed for light microscopy and isolation of RNA. Expression of cytokine and extracellular matrix mRNA abundance was evaluated by slot-blot analysis and cellular localization by in situ hybridization and immunochemistry.
RESULTS: One of the cytokines responsible for the inflammatory phase (IL-1 alpha) is elevated at 2 weeks, returns to normal baseline values, then increases at 8 weeks, remaining elevated until 26 weeks when lung fibrosis appears. Transforming growth factor-beta (TGF beta), a proliferative cytokine, is elevated at 2 weeks, persists until 8 weeks, and then returns to baseline values. In parallel with the cytokine cascade, the fibrogenic markers for CI/CIII/IV (collagen genes) correlate by showing a similar early and then later elevation of activity. For instance, the collagen gene expression of CI/CIII is a biphasic response with an initial increase at 1-2 weeks that remits at 8 weeks, remains inactive from 8 to 16 weeks, and then becomes elevated at 6 months when collagen deposition is recognized histopathologically.
CONCLUSION: These studies clearly demonstrate the early and persistent elevation of cytokine production following pulmonary irradiation. The temporal relationship between the elevation of specific cytokines and the histological and biochemical evidence of fibrosis serves to illustrate the continuum of response, which, we believe, underlies pulmonary radiation reactions and supports the concept of a perpetual cascade of cytokines produced immediately after irradiation, prompting collagen genes to turn on, and persisting until the expression of late effects becomes apparent pathologically and clinically.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7642437     DOI: 10.1016/0360-3016(95)00095-G

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  161 in total

Review 1.  Early and late effects of radiation treatment for prevention of coronary restenosis: a critical appraisal.

Authors:  O F Bertrand; S Lehnert; R Mongrain; M G Bourassa
Journal:  Heart       Date:  1999-12       Impact factor: 5.994

2.  Early alterations in cytokine expression in adult compared to developing lung in mice after radiation exposure.

Authors:  Carl J Johnston; Eric Hernady; Christina Reed; Sally W Thurston; Jacob N Finkelstein; Jacqueline P Williams
Journal:  Radiat Res       Date:  2010-04       Impact factor: 2.841

3.  Animal models for medical countermeasures to radiation exposure.

Authors:  Jacqueline P Williams; Stephen L Brown; George E Georges; Martin Hauer-Jensen; Richard P Hill; Amy K Huser; David G Kirsch; Thomas J Macvittie; Kathy A Mason; Meetha M Medhora; John E Moulder; Paul Okunieff; Mary F Otterson; Michael E Robbins; James B Smathers; William H McBride
Journal:  Radiat Res       Date:  2010-04       Impact factor: 2.841

4.  Heart irradiation as a risk factor for radiation pneumonitis.

Authors:  Ellen X Huang; Andrew J Hope; Patricia E Lindsay; Marco Trovo; Issam El Naqa; Joseph O Deasy; Jeffrey D Bradley
Journal:  Acta Oncol       Date:  2010-09-28       Impact factor: 4.089

Review 5.  Radiation-induced intestinal inflammation.

Authors:  Meritxell Molla; Julian Panes
Journal:  World J Gastroenterol       Date:  2007-06-14       Impact factor: 5.742

6.  After the bomb drops: a new look at radiation-induced multiple organ dysfunction syndrome (MODS).

Authors:  Jacqueline P Williams; William H McBride
Journal:  Int J Radiat Biol       Date:  2011-03-21       Impact factor: 2.694

7.  Does the presence of emphysema increase the risk of radiation pneumonitis in lung cancer patients?

Authors:  G Kasymjanova; R T Jagoe; C Pepe; L Sakr; V Cohen; D Small; T M Muanza; J S Agulnik
Journal:  Curr Oncol       Date:  2018-12-01       Impact factor: 3.677

Review 8.  Modeling radiation-induced lung injury: lessons learned from whole thorax irradiation.

Authors:  Tyler A Beach; Angela M Groves; Jacqueline P Williams; Jacob N Finkelstein
Journal:  Int J Radiat Biol       Date:  2018-10-25       Impact factor: 2.694

9.  Late treatment with imatinib mesylate ameliorates radiation-induced lung fibrosis in a mouse model.

Authors:  Minglun Li; Amir Abdollahi; Hermann-Josef Gröne; Kenneth E Lipson; Claus Belka; Peter E Huber
Journal:  Radiat Oncol       Date:  2009-12-21       Impact factor: 3.481

10.  Early administration of IL-6RA does not prevent radiation-induced lung injury in mice.

Authors:  Toshiyuki Ogata; Hideya Yamazaki; Teruki Teshima; Ayaka Kihara; Yuko Suzumoto; Takehiro Inoue; Norihiro Nishimoto; Nariaki Matsuura
Journal:  Radiat Oncol       Date:  2010-04-07       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.